Elstar Therapeutics Closes $39M Series A Financing to Support Development of its Universal Targeted Immunotherapy … – Business Wire (press release)
FierceBiotech |
Elstar Therapeutics Closes $39M Series A Financing to Support Development of its Universal Targeted Immunotherapy …
Business Wire (press release) CAMBRIDGE, Mass.–(BUSINESS WIRE)–Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapies, today announced the closing of a $39M Series A … Big Pharma vets bag $39M to drive I/O firm Elstar forward |
